StockData
Korro Bio, Inc. logo

Korro Bio, Inc. (KRRO) stock

KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$12.32−0.39 (-3.07%)

Close on Nov 17, 2026Market cap $181.42MP/E –Yield –

Korro Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

No price to book ratio figures for Korro Bio

Korro Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Korro Bio figures

See a number that looks wrong?